Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
about
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesImpact of thromboprophylaxis across the US acute care settingTreatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.A decision model to estimate a risk threshold for venous thromboembolism prophylaxis in hospitalized medical patients.Pharmacological and clinical differences between low-molecular-weight heparins: implications for prescribing practice and therapeutic interchange.Venous thromboembolism prophylaxis: Solutions are in our hands.Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsThe economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs.Primary prevention of venous thromboembolism in elderly medical patientsEconomic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review.
P2860
Q24633010-8E0935E6-99E3-422E-B5D9-7C6FD1157AF1Q28651190-97E7A2BF-E0B4-4191-9FFF-088B58DB3649Q33399580-ACC9FE64-7D05-4066-BBEB-4DBDD8CAA778Q33440651-432186DC-7463-410D-BA18-36E405398F5AQ33685447-039B2101-819A-4361-9705-81C2356577A1Q35092231-4EF87C98-AE94-4414-A471-D4B5D0E42D43Q35752603-F304FE13-7DD4-472A-97B3-FD439C1E3FF9Q35939263-C2C4E6F6-ABF9-416B-B124-E5C926FACA05Q36445585-3489E106-FD32-4B85-9181-2CC93E28DDBBQ37316796-F73FC9F2-5C8F-4AC6-86DF-8D8EDD2EC58CQ37661478-737BBCDC-1ED4-47B7-BA53-C2141E203639
P2860
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Cost effectiveness of thrombop ...... cutely ill medical inpatients.
@ast
Cost effectiveness of thrombop ...... cutely ill medical inpatients.
@en
type
label
Cost effectiveness of thrombop ...... cutely ill medical inpatients.
@ast
Cost effectiveness of thrombop ...... cutely ill medical inpatients.
@en
prefLabel
Cost effectiveness of thrombop ...... cutely ill medical inpatients.
@ast
Cost effectiveness of thrombop ...... cutely ill medical inpatients.
@en
P1476
Cost effectiveness of thrombop ...... acutely ill medical inpatients
@en
P2093
David Thompson
Samuel Z Goldhaber
P304
P577
2004-09-01T00:00:00Z